Skip to main content
Top
Published in:

26-07-2023 | Pancreatic Cancer | Correction

Correction to: Healthy lifestyle index and risk of pancreatic cancer in the Women’s Health Initiative

Authors: Rita Peila, Mace Coday, Tracy E. Crane, Nazmus Saquib, Aladdin H. Shadyab, Fred K. Tabung, Xiaochen Zhang, Jean Wactawski-Wende, Thomas E. Rohan

Published in: Cancer Causes & Control | Issue 12/2023

Login to get access
Metadata
Title
Correction to: Healthy lifestyle index and risk of pancreatic cancer in the Women’s Health Initiative
Authors
Rita Peila
Mace Coday
Tracy E. Crane
Nazmus Saquib
Aladdin H. Shadyab
Fred K. Tabung
Xiaochen Zhang
Jean Wactawski-Wende
Thomas E. Rohan
Publication date
26-07-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 12/2023
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01754-3

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more